Issued Patents All Time
Showing 26–44 of 44 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 5840564 | Tussue plasminogen activator having zymogenic or fibrin specific properties | Stephen Anderson, William F. Bennett, David Bottstein, Deborah L. Higgins, Mark Zoller | 1998-11-24 |
| 5837241 | Method of treating heart failure using leukemia inhibitory factor antagonists optionally with endothelin antagonists | Napoleone Ferrara, Kathleen King, Elizabeth Luis, Jennie P. Mather | 1998-11-17 |
| 5821105 | Tissue plasminogen activator having zymognic or fibrin specific properties | Stephen Anderson, William F. Bennett, David Botstkin, Deborah L. Higgins, Mark Zoller | 1998-10-13 |
| 5770426 | Tissue plasminogen activator having zymogenic or fibrin specific properties | Stephen Anderson, William F. Bennett, David Botstein, Deborah L. Higgins, Mark Zoller | 1998-06-23 |
| 5756093 | Tissue plasminogen activator variants | Herbert L. Heyneker, Gordon A. Vehar, William F. Bennett | 1998-05-26 |
| 5736134 | Tissue plasminogen activator variants | Herbert L. Heyneker, Gordon A. Vehar, William F. Bennett | 1998-04-07 |
| 5728567 | Tissue plasminogen activator having zymogenic or fibrin specific properties | Stephen Anderson, William F. Bennett, David Botstein, Deborah L. Higgins, Mark Zoller | 1998-03-17 |
| 5714145 | Tissue plasminogen activator having zymogenic or fibrin specific properties | Stephen Anderson, William F. Bennett, David Botstein, Deborah L. Higgins, Mark Zoller | 1998-02-03 |
| 5661122 | Treatment of congestive heart failure | Ross G. Clark, Hongkui Jin, Renhui Yang | 1997-08-26 |
| 5616486 | Tissue plasminogen activator having zymogenic or fibrin specific properties | Stephen Anderson, William F. Bennett, David Botstein, Deborah L. Higgins, Mark Zoller | 1997-04-01 |
| 5614190 | Tissue plasminogen activator having zymogenic or fibrin specific properties | Stephen Anderson, William F. Bennett, David Botstein, Deborah L. Higgins, Mark Zoller | 1997-03-25 |
| 5612029 | Tissue plasminogen activator glycosylation variants with improved therapeutic properties | William F. Bennett, Bruce Keyt | 1997-03-18 |
| 5610134 | Treatment of congestive heart failure | Ross G. Clark, Hongkui Jin, Renhui Yang | 1997-03-11 |
| 5573762 | Use of leukemia inhibitory factor specific antibodies and endothelin antagonists for treatment of cardiac hypertrophy | Napoleone Ferrara, Kathleen King, Elizabeth Luis, Jennie P. Mather | 1996-11-12 |
| 5520913 | Tissue plasminogen activator having zymogenic properties | Stephen Anderson, William F. Bennett, David Botstein, Deborah L. Higgins, Mark Zoller | 1996-05-28 |
| 5411871 | Method for identifying tissue plasminogen activator having zymogenic or fibrin specific properties | Stephen Anderson, William F. Bennett, David Botstein, Deborah L. Higgins, Mark Zoller | 1995-05-02 |
| 5405771 | Tissue plasminogen activator having zymogenic or fibrin specific properties | Stephen Anderson, William F. Bennett, David Botstein, Deborah L. Higgins, Mark Zoller | 1995-04-11 |
| 5262170 | Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells | Stephen Anderson, William F. Bennett, David Botstein, Deborah L. Higgins, Mark Zoller | 1993-11-16 |
| 5108901 | Tissue plasminogen activator having zymogenic or fibrin specific properties | Stephen Anderson, William F. Bennett, David Botstein, Deborah L. Higgins, Mark Zoller | 1992-04-28 |